Logo image of ICU

SEASTAR MEDICAL HOLDING CORP (ICU) Stock Price, Quote, News and Overview

NASDAQ:ICU - Nasdaq - US81256L2034 - Common Stock - Currency: USD

1.91  -0.37 (-16.23%)

Premarket: 1.85 -0.06 (-3.14%)

ICU Quote, Performance and Key Statistics

SEASTAR MEDICAL HOLDING CORP

NASDAQ:ICU (2/4/2025, 8:00:02 PM)

Premarket: 1.85 -0.06 (-3.14%)

1.91

-0.37 (-16.23%)

Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment
Statistics
52 Week High42.92
52 Week Low1.5
Market Cap8.52M
Shares4.46M
Float4.28M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)N/A N/A
IPO01-26 2021-01-26


ICU short term performance overview.The bars show the price performance of ICU in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -20 -40 -60

ICU long term performance overview.The bars show the price performance of ICU in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of ICU is 1.91 USD. In the past month the price decreased by -9.05%. In the past year, price decreased by -91.12%.

SEASTAR MEDICAL HOLDING CORP / ICU Daily stock chart

ICU Latest News, Press Releases and Analysis

News Image
15 hours ago - Chartmill

Unusual volume stocks in Tuesday's session

Let's have a look at the stocks with an unusual volume in today's session.

News Image
2 days ago - SeaStar Medical Holding Corporation

SeaStar Medical Announces Closing of $6 Million Registered Direct Offering Priced At-the-Market

DENVER, Feb. 03, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU) (SeaStar Medical) today announced the closing of its...

News Image
5 days ago - SeaStar Medical Holding Corporation

SeaStar Medical Announces $6 Million Registered Direct Offering Priced At-the-Market

DENVER, Jan. 31, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU) (SeaStar Medical) today announced it has entered into a...

News Image
14 days ago - SeaStar Medical Holding Corporation

SeaStar Medical Activates 15th Site for its Adult Acute Kidney Injury Pivotal Trial

DENVER, Jan. 22, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing...

News Image
23 days ago - SeaStar Medical Holding Corporation

FDA Approves Feasibility Study with SeaStar Medical’s Selective Cytopheretic Device in Adults with Cardiorenal Syndrome

Study to be conducted under $3.6 million NIH grant  DENVER, Jan. 13, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a...

News Image
a month ago - SeaStar Medical Holding Corporation

SeaStar Medical Begins Shipping QUELIMMUNE to a Fourth Hospital Customer

DENVER, Jan. 08, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing...

ICU Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
ABT ABBOTT LABORATORIES 27.64 223.92B
ISRG INTUITIVE SURGICAL INC 79.08 206.46B
BSX BOSTON SCIENTIFIC CORP 43.87 152.60B
SYK STRYKER CORP 32.19 149.59B
MDT MEDTRONIC PLC 17.33 116.65B
BDX BECTON DICKINSON AND CO 18.42 70.30B
EW EDWARDS LIFESCIENCES CORP 26.72 42.07B
GEHC GE HEALTHCARE TECHNOLOGY 20.6 39.72B
IDXX IDEXX LABORATORIES INC 41.34 38.08B
RMD RESMED INC 27.2 35.30B
DXCM DEXCOM INC 51.45 34.16B
PHG KONINKLIJKE PHILIPS NVR- NY 20.23 25.29B

About ICU

Company Profile

ICU logo image SeaStar Medical Holding Corp is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Denver, Colorado and currently employs 12 full-time employees. The company went IPO on 2021-01-26. SeaStar Medical Holding Corporation is a commercial-stage medical technology company. The firm is focused on developing extracorporeal therapies to reduce the consequences of hyperinflammation on vital organs. The firm's technologies rely on science to provide life-saving solutions to critically ill patients. The firm develops and commercializes cell-directed extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The firm uses its Selective Cytopheretic Device (SCD) technology platform to clinically validate several acute organ injury indications, including kidneys and lungs. Its investigational SCD is an extracorporeal synthetic membrane device designed to integrate into existing continuous renal replacement therapy (CRRT) systems that are commonly installed in hospitals throughout the United States.

Company Info

SEASTAR MEDICAL HOLDING CORP

3513 Brighton Blvd, Suite 410

Denver COLORADO US

Employees: 12

Company Website: https://seastarmedical.com

Investor Relations: https://investors.seastarmedical.com/overview/default.aspx

Phone: 18444278100

ICU FAQ

What is the stock price of ICU?

The current stock price of ICU is 1.91 USD.


What is the symbol for SEASTAR MEDICAL HOLDING CORP stock?

The exchange symbol of SEASTAR MEDICAL HOLDING CORP is ICU and it is listed on the Nasdaq exchange.


On which exchange is ICU stock listed?

ICU stock is listed on the Nasdaq exchange.


Is ICU a good stock to buy?

Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for ICU, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of ICU.


Does ICU stock pay dividends?

ICU does not pay a dividend.


What is the Price/Earnings (PE) ratio of ICU?

ICU does not have a PE ratio as the earnings reported over the last twelve months were negative (-12.38).


What is the Short Interest ratio of ICU stock?

The outstanding short interest for ICU is 9.73% of its float.


ICU Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

ICU Financial Highlights

Over the last trailing twelve months ICU reported a non-GAAP Earnings per Share(EPS) of -12.38. The EPS decreased by -16.01% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -660.4%
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%87.78%
Sales Q2Q%N/A
EPS 1Y (TTM)-16.01%
Revenue 1Y (TTM)N/A

ICU Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 80% to ICU. The Buy consensus is the average rating of analysts ratings from 5 analysts.


Ownership
Inst Owners4.13%
Ins Owners2.01%
Short Float %9.73%
Short Ratio0.88
Analysts
Analysts80
Price Target7.14 (273.82%)
EPS Next Y73.04%
Revenue Next YearN/A